Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence.

Divalproex, a GABA agonist, may be a useful agent in the treatment of tobacco dependence. Cue reactivity assessment paradigms are ideally suited to explore basic mechanisms underlying the pharmacological effects of medications that purport to have efficacy for smoking cessation. Our primary goal in the current study was to examine the effects of divalproex on in-treatment reactivity to smoking-relevant and affective cues, and to determine if these reactions were predictive of posttreatment smoking behavior. There were 120 nicotine dependent smokers enrolled in an 8-week double-blind clinical trial and randomly assigned to either divalproex or placebo conditions. Of these, 72 smokers (60% female) who achieved a minimal level of abstinence underwent an in-treatment cue reactivity assessment. Contrary to expectations, divalproex was associated with greater craving and arousal during smoking cue presentation. Divalproex also inhibited cardiovascular response to pleasant cues. Although no significant differences in cessation-related outcomes between divalproex- and placebo-treated participants were observed, cue-elicited craving to smoke predicted end-of-treatment and posttreatment smoking rates. These findings suggest that in-treatment cue reactivity assessment may proactively and dynamically inform ongoing treatment as well as provide a tool for screening potential medications for smoking cessation.

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  R. Perera,et al.  Nicotine replacement therapy for smoking cessation. , 2012, The Cochrane database of systematic reviews.

[3]  Kenneth W Lin,et al.  Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[4]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[5]  C. Bowden.  Anticonvulsants in bipolar disorders: current research and practice and future directions. , 2009, Bipolar disorders.

[6]  Tobacco Use and Dependence Guideline Panel.  Treating Tobacco Use and Dependence: 2008 Update , 2008 .

[7]  M. Reid,et al.  Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers , 2007, Psychopharmacology.

[8]  G. Kaplan,et al.  High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. , 2007, Experimental and clinical psychopharmacology.

[9]  R. Tyndale,et al.  Non-nicotinic therapies for smoking cessation. , 2007, Annual review of pharmacology and toxicology.

[10]  Patrick O. Smith,et al.  Pretreatment cue reactivity predicts end-of-treatment smoking. , 2006, Addictive behaviors.

[11]  C. Lerman,et al.  Medication screening for smoking cessation: a proposal for new methodologies , 2006, Psychopharmacology.

[12]  H. de Wit,et al.  Effects of d-amphetamine and smoking abstinence on cue-induced cigarette craving. , 2005, Experimental and clinical psychopharmacology.

[13]  T. George,et al.  Smoking cue reactivity in schizophrenia: Effects of a nicotinic receptor antagonist , 2005, Biological Psychiatry.

[14]  H. de Wit,et al.  Effects of haloperidol on reactions to smoking cues in humans , 2005, Behavioural pharmacology.

[15]  A. Markou,et al.  Role of γ‐Aminobutyric Acid (GABA) and Metabotropic Glutamate Receptors in Nicotine Reinforcement: Potential Pharmacotherapies for Smoking Cessation , 2004, Annals of the New York Academy of Sciences.

[16]  E. Nunes,et al.  Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. , 2004, The American journal on addictions.

[17]  K. Hutchison,et al.  Olanzapine attenuates cue-elicited craving for tobacco , 2003, Psychopharmacology.

[18]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[19]  D. Drobes.  Cue reactivity in alcohol and tobacco dependence. , 2002, Alcoholism, clinical and experimental research.

[20]  K. Brady,et al.  The use of divalproex in alcohol relapse prevention: a pilot study. , 2002, Drug and alcohol dependence.

[21]  H. Mansvelder,et al.  Synaptic Mechanisms Underlie Nicotine-Induced Excitability of Brain Reward Areas , 2002, Neuron.

[22]  S Shiffman,et al.  A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. , 2001, Addiction.

[23]  L. Cox,et al.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[24]  L. Stead,et al.  Anxiolytics for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[25]  H. Mansvelder,et al.  Long-Term Potentiation of Excitatory Inputs to Brain Reward Areas by Nicotine , 2000, Neuron.

[26]  K. Brady,et al.  Divalproex in the Treatment of Alcohol Withdrawal , 2000, The American journal of drug and alcohol abuse.

[27]  B. Carter,et al.  Meta-analysis of cue-reactivity in addiction research. , 1999, Addiction.

[28]  A. Sirota,et al.  Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results , 1999, Psychopharmacology.

[29]  D. Abrams,et al.  Scripted imagery manipulations and smoking cue reactivity in a clinical sample of self-quitters. , 1998, Experimental and clinical psychopharmacology.

[30]  T. Brandon,et al.  Reactivity to instructed smoking availability and environmental cues: evidence with urge and reaction time. , 1998, Experimental and clinical psychopharmacology.

[31]  S. Tiffany,et al.  Induction of smoking urge through imaginal and in vivo procedures: physiological and self-report manifestations. , 1997, Journal of abnormal psychology.

[32]  Stephen T. Tiffany,et al.  Production of smoking urges through imagery: The impact of affect and smoking abstinence. , 1996 .

[33]  M. Bradley,et al.  Measuring emotion: the Self-Assessment Manikin and the Semantic Differential. , 1994, Journal of behavior therapy and experimental psychiatry.

[34]  M. Bradley,et al.  Looking at pictures: affective, facial, visceral, and behavioral reactions. , 1993, Psychophysiology.

[35]  B. Rosner,et al.  Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. , 1992, Addictive behaviors.

[36]  S. Tiffany,et al.  The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.

[37]  Karl Fagerstrom,et al.  Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.

[38]  A. J. Fridlund,et al.  Guidelines for human electromyographic research. , 1986, Psychophysiology.

[39]  E. Diener,et al.  The independence of positive and negative affect. , 1984, Journal of personality and social psychology.

[40]  G. Ben-Shakhar,et al.  Publication recommendations for electrodermal measurements. , 1981, Psychophysiology.

[41]  C. Husten,et al.  How to help your patients stop smoking. , 1978, American family physician.

[42]  Z. Šidák.  Rectangular Confidence Regions for the Means of Multivariate Normal Distributions , 1967 .

[43]  D. Ziedonis,et al.  Developments in pharmacotherapy for tobacco dependence: past, present and future. , 2006, Drug and alcohol review.

[44]  P. Lang.  International affective picture system (IAPS) : affective ratings of pictures and instruction manual , 2005 .

[45]  A. Markou,et al.  Repeated Administration of the GABAB Receptor Agonist CGP44532 Decreased Nicotine Self-Administration, and Acute Administration Decreased Cue-Induced Reinstatement of Nicotine-Seeking in Rats , 2005, Neuropsychopharmacology.

[46]  S. Vosburg,et al.  Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex , 2004, Neuropsychopharmacology.

[47]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[48]  W. Kraft,et al.  How to help your patients , 1999 .

[49]  P. Lang,et al.  International Affective Picture System (IAPS): Instruction Manual and Affective Ratings (Tech. Rep. No. A-4) , 1999 .

[50]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[51]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[52]  T J Payne,et al.  Exposure to smoking-relevant cues: effects on desire to smoke and topographical components of smoking behavior. , 1991, Addictive behaviors.

[53]  T. Baker,et al.  Postcessation cigarette use: the process of relapse. , 1990, Addictive behaviors.

[54]  D. Abrams,et al.  Responses to smoking-related stimuli and early relapse to smoking. , 1989, Addictive behaviors.

[55]  P M Monti,et al.  Reactivity to high risk situations and smoking cessation outcome. , 1989, Journal of substance abuse.

[56]  D. Abrams,et al.  Reactivity to smoking cues and relapse: two studies of discriminant validity. , 1988, Behaviour research and therapy.